Featured Blog
-
October 22, 2024
This phase III interventional, randomized, open-label trial investigates the safety and efficacy of a new second-line treatment for advanced or metastatic breast cancer. Treating advanced or metastat...
Browse blogs by hospital
Share this
All Blogs
-
January 07, 2018
By MedStar Health Research Institute
In December, MHRI associates took some time out of their busy schedules to celebrate the successes of 2017 with their fellow associates. These events are also our opportunity to recognize associ...
-
January 07, 2018
By MedStar Health Research Institute
An analysis of the effect of diet on postmenopausal women as part of the Women’s Health Initiative shows that reducing fats and increasing vegetable, fruit, and grain intake can reduce the risk of nee...
-
January 07, 2018
By MedStar Health Research Institute
Congratulations to all MedStar researchers who had articles published in December 2017. The selected articles and link to PubMed provided below represent the body of work completed by MedStar Health i...
-
January 07, 2018
By MedStar Health Research Institute
Recently published research at MedStar investigated the link between the educational level of study participants and treatment preferences for type 2 diabetes medication. This stratification study sou...
-
January 07, 2018
By MedStar Health Research Institute
The Revised Common Rule compliance date is quickly approaching on January 19, 2018. The Office of Research Integrity and MHRI leadership are working to ensure required changes to our policies and proc...
-
December 14, 2017
In the 1990s, the Food and Drug Administration (FDA) approved a treatment for bladder cancer called Bacillus Calmette-Guerin therapy, or BCG, which stimulates the immune system and helps keep patients...